Jupiter, Fla., July 31/PR Newswire-First Call/ — Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced that it will report its financial results for the second quarter ended June 30, 2012 after market close on Monday, August 13, 2012 and will host a conference call at 5:00 p.m. Eastern Time to discuss those results.
In order to participate in the live session, please use the following dial-in numbers five to ten minutes prior to start time:
Calling from the United States or Canada: 888-812-8522
Calling from other countries: 913-312-0980
Confirmation Code: 4245750
A replay of the conference call will be available on Dyadic’s website (www.dyadic.com) shortly after the live event.
Dyadic is a global biotechnology company that uses its patented and proprietary technologies for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries.
CAUTIONARY STATEMENT FOR FORWARD-LOOKING STATEMENTS
Certain statements contained in this press release are forward- looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.
Dyadic International, Inc.
Adam J. Morgan, Esq.
Vice President General Counsel & Business Development